Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 489

1.

Solubility and permeability improvement of quercetin by an interaction between α-glucosyl stevia nano-aggregates and hydrophilic polymer.

Uchiyama H, Wada Y, Hatanaka Y, Hirata Y, Taniguchi M, Kadota K, Tozuka Y.

J Pharm Sci. 2019 Jan 14. pii: S0022-3549(19)30014-0. doi: 10.1016/j.xphs.2019.01.007. [Epub ahead of print]

PMID:
30653971
2.

HOXA10 expression profiling in prostate cancer.

Hatanaka Y, de Velasco MA, Oki T, Shimizu N, Nozawa M, Yoshimura K, Yoshikawa K, Nishio K, Uemura H.

Prostate. 2019 Jan 6. doi: 10.1002/pros.23761. [Epub ahead of print]

PMID:
30614022
3.

Evaluation of the safety, effectiveness, and health-related QOL impact of early rehabilitation in patients with nephrotic syndrome.

Iwai K, Hatanaka Y, Kawaguchi T, Araki SI.

Clin Exp Nephrol. 2019 Jan 3. doi: 10.1007/s10157-018-1681-0. [Epub ahead of print]

PMID:
30607657
4.

[The isometric knee extension strength threshold for maintaining walking speed and step length in older male inpatients].

Tada M, Omori Y, Mogamiya T, Sasaki S, Katata H, Ishiyama D, Koyama S, Hatanaka Y, Yotaro S.

Nihon Ronen Igakkai Zasshi. 2018;55(4):624-631. doi: 10.3143/geriatrics.55.624. Japanese.

5.

Correction to " Anti-Selective Asymmetric Nitro-Michael Reaction of Furanones: Diastereocontrol by Catalyst".

Sekikawa T, Kitaguchi T, Kitaura H, Minami T, Hatanaka Y.

Org Lett. 2018 Nov 20. doi: 10.1021/acs.orglett.6b01540. [Epub ahead of print] No abstract available.

PMID:
30457339
6.

Cytoplasmic CD133 expression correlates with histologic differentiation and is a significant prognostic factor in extrahepatic bile duct cancer and gallbladder cancer.

Mizukami T, Kamachi H, Mitsuhashi T, Einama T, Hatanaka Y, Kamiyama T, Taketomi A.

Oncol Lett. 2018 Nov;16(5):6423-6430. doi: 10.3892/ol.2018.9499. Epub 2018 Sep 25.

7.

Anastomosing haemangioma with fatty changes in the perirenal space: a lesion mimicking liposarcoma.

Kishida N, Sentani K, Terada H, Honda Y, Goto K, Hatanaka Y, Kohashi K, Oda Y, Iwata J, Yasui W, Shinmei S, Hayashi T, Teishima J, Matsubara A, Nakamura Y, Iida M, Awai K.

BJR Case Rep. 2017 Nov 1;4(2):20170022. doi: 10.1259/bjrcr.20170022. eCollection 2018.

8.

The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model.

Mizukami T, Kamachi H, Fujii Y, Matsuzawa F, Einama T, Kawamata F, Kobayashi N, Hatanaka Y, Taketomi A.

Oncotarget. 2018 Sep 18;9(73):33844-33852. doi: 10.18632/oncotarget.26117. eCollection 2018 Sep 18.

9.

Molecular dynamics study of thermodynamic stability and dynamics of [Li(glyme)]+ complex in lithium-glyme solvate ionic liquids.

Shinoda W, Hatanaka Y, Hirakawa M, Okazaki S, Tsuzuki S, Ueno K, Watanabe M.

J Chem Phys. 2018 May 21;148(19):193809. doi: 10.1063/1.5009814.

PMID:
30307251
10.

Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive rats.

Negishi E, Fukuda N, Otsuki T, Katakawa M, Komatsu K, Chen L, Tanaka S, Kobayashi H, Hatanaka Y, Ueno T, Endo M, Mashimo T, Nishiyama A, Abe M.

Am J Physiol Renal Physiol. 2018 Sep 26. doi: 10.1152/ajprenal.00370.2018. [Epub ahead of print]

PMID:
30256128
11.

Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma.

Kato T, Jin CS, Lee D, Ujiie H, Fujino K, Hu HP, Wada H, Wu L, Chen J, Weersink RA, Kanno H, Hatanaka Y, Hatanaka KC, Kaga K, Matsui Y, Matsuno Y, De Perrot M, Wilson BC, Zheng G, Yasufuku K.

Int J Oncol. 2018 Nov;53(5):2034-2046. doi: 10.3892/ijo.2018.4555. Epub 2018 Sep 7.

12.

Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia.

Tanaka S, Ueno T, Tsunemi A, Nakamura Y, Kobayashi H, Hatanaka Y, Haketa A, Fukuda N, Soma M, Abe M.

Intern Med. 2019 Jan 15;58(2):251-257. doi: 10.2169/internalmedicine.0952-18. Epub 2018 Sep 12.

13.

Multiple Cellular Transport and Binding Processes of Unesterified Docosahexaenoic Acid in Outer Blood-Retinal Barrier Retinal Pigment Epithelial Cells.

Tachikawa M, Akanuma SI, Imai T, Okayasu S, Tomohiro T, Hatanaka Y, Hosoya KI.

Biol Pharm Bull. 2018;41(9):1384-1392. doi: 10.1248/bpb.b18-00185.

14.

Bosniak Category III Renal Cysts Caused by Crizotinib in an Anaplastic Lymphoma Kinase Gene-Rearranged Non-Small Cell Lung Cancer Patient.

Okubo K, Sato A, Nakamoto K, Hatanaka Y, Isono M, Hatanaka M, Suyama Y, Shinmoto H, Asano T.

Urology. 2018 Nov;121:e3-e4. doi: 10.1016/j.urology.2018.08.008. Epub 2018 Aug 21.

PMID:
30142403
15.

Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1.

Nishiyama K, Maruyama R, Niinuma T, Kai M, Kitajima H, Toyota M, Hatanaka Y, Igarashi T, Kobayashi JI, Ogi K, Dehari H, Miyazaki A, Yorozu A, Yamamoto E, Idogawa M, Sasaki Y, Sugai T, Tokino T, Hiratsuka H, Suzuki H.

Cell Death Dis. 2018 Aug 1;9(8):826. doi: 10.1038/s41419-018-0893-2.

16.

[Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].

Uchida Y, Hokkoku K, Hatanaka Y, Kikuchi Y, Tashiro H, Sonoo M.

Rinsho Shinkeigaku. 2018 Aug 31;58(8):485-491. doi: 10.5692/clinicalneurol.cn-001157. Epub 2018 Jul 31. Japanese.

PMID:
30068810
17.

The Association of Variations in Hip and Pelvic Geometry With Pregnancy-Related Sacroiliac Joint Pain Based on a Longitudinal Analysis.

Ji X, Morino S, Iijima H, Ishihara M, Kawagoe M, Umezaki F, Hatanaka Y, Yamashita M, Tsuboyama T, Aoyama T.

Spine (Phila Pa 1976). 2019 Jan 15;44(2):E67-E73. doi: 10.1097/BRS.0000000000002774.

PMID:
29979361
18.

Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report.

Ito H, Hatanaka Y, Fukami Y, Harada Y, Kobayashi R, Okada H, Uchibori A, Chiba A, Okuda S.

BMC Neurol. 2018 May 23;18(1):72. doi: 10.1186/s12883-018-1077-5.

19.

Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.

Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R.

Mol Neurodegener. 2018 May 11;13(1):21. doi: 10.1186/s13024-018-0257-5.

20.

Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma.

Ueno T, Tsuchikawa T, Hatanaka KC, Hatanaka Y, Mitsuhashi T, Nakanishi Y, Noji T, Nakamura T, Okamura K, Matsuno Y, Hirano S.

Oncotarget. 2018 Apr 13;9(28):20034-20047. doi: 10.18632/oncotarget.25050. eCollection 2018 Apr 13.

21.

Repetitive Discharge in a Case of Isaacs Syndrome with Burning Sensation.

Kurihara M, Sugimoto I, Hatanaka Y, Sakurai Y.

Intern Med. 2018 Sep 1;57(17):2597. doi: 10.2169/internalmedicine.0392-17. Epub 2018 Apr 27. No abstract available.

22.

PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer.

Ishida N, Baba M, Hatanaka Y, Hagio K, Okada H, Hatanaka KC, Togashi K, Matsuno Y, Yamashita H.

Oncotarget. 2018 Apr 3;9(25):17711-17724. doi: 10.18632/oncotarget.24845. eCollection 2018 Apr 3.

23.

Increased uptake on 18 F-fluorodeoxyglucose positron emission tomography/computed tomography is indicative of occult skin lesions in a patient with intravascular large B-cell lymphoma.

Matsukura K, Hokkoku K, Shiraoka A, Yang L, Takahashi Y, Hatanaka Y, Sasajima Y, Tada Y, Sonoo M.

J Dermatol. 2018 Sep;45(9):e254-e255. doi: 10.1111/1346-8138.14302. Epub 2018 Mar 22. No abstract available.

PMID:
29569289
24.

Clinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Takashima Y, Sakakibara-Konishi J, Hatanaka Y, Hatanaka KC, Ohhara Y, Oizumi S, Hida Y, Kaga K, Kinoshita I, Dosaka-Akita H, Matsuno Y, Nishimura M.

Clin Lung Cancer. 2018 Jul;19(4):352-359.e1. doi: 10.1016/j.cllc.2018.02.004. Epub 2018 Feb 19.

PMID:
29544718
25.

Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.

Mizushima T, Ohnishi S, Shimizu Y, Hatanaka Y, Hatanaka KC, Kuriki Y, Kamiya M, Homma A, Yamamoto K, Ono S, Urano Y, Sakamoto N.

Head Neck. 2018 Jul;40(7):1466-1475. doi: 10.1002/hed.25126. Epub 2018 Mar 6.

PMID:
29509281
26.

Peroxiredoxin as a functional endogenous antioxidant enzyme in pronuclei of mouse zygotes.

Morita K, Tokoro M, Hatanaka Y, Higuchi C, Ikegami H, Nagai K, Anzai M, Kato H, Mitani T, Taguchi Y, Yamagata K, Hosoi Y, Miyamoto K, Matsumoto K.

J Reprod Dev. 2018 Apr 13;64(2):161-171. doi: 10.1262/jrd.2018-005. Epub 2018 Mar 2.

27.

Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.

Sato M, Yamamoto H, Hatanaka Y, Nishijima T, Jiromaru R, Yasumatsu R, Taguchi K, Masuda M, Nakagawa T, Oda Y.

Pathol Res Pract. 2018 Apr;214(4):586-592. doi: 10.1016/j.prp.2017.12.016. Epub 2018 Jan 3.

PMID:
29496310
28.

DJ-1 is a useful biomarker for invasive extrahepatic cholangiocarcinoma.

Tabata Y, Nakanishi Y, Hatanaka KC, Hatanaka Y, Tsuchikawa T, Okamura K, Noji T, Shichinohe T, Matsuno Y, Hirano S.

Hum Pathol. 2018 Jun;76:28-36. doi: 10.1016/j.humpath.2018.02.010. Epub 2018 Feb 13.

PMID:
29447925
29.

Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.

Wardell CP, Fujita M, Yamada T, Simbolo M, Fassan M, Karlic R, Polak P, Kim J, Hatanaka Y, Maejima K, Lawlor RT, Nakanishi Y, Mitsuhashi T, Fujimoto A, Furuta M, Ruzzenente A, Conci S, Oosawa A, Sasaki-Oku A, Nakano K, Tanaka H, Yamamoto Y, Michiaki K, Kawakami Y, Aikata H, Ueno M, Hayami S, Gotoh K, Ariizumi SI, Yamamoto M, Yamaue H, Chayama K, Miyano S, Getz G, Scarpa A, Hirano S, Nakamura T, Nakagawa H.

J Hepatol. 2018 May;68(5):959-969. doi: 10.1016/j.jhep.2018.01.009. Epub 2018 Jan 31.

30.

Nitrite-reducing ability is related to growth inhibition by nitrite in Rhodobacter sphaeroides f. sp. denitrificans.

Shimizu T, Horiguchi K, Hatanaka Y, Masuda S, Shimada K, Matsuura K, Haruta S.

Biosci Biotechnol Biochem. 2018 Jan;82(1):148-151. doi: 10.1080/09168451.2017.1412247. Epub 2018 Jan 3.

PMID:
29297256
31.

Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors.

Hontani K, Tsuchikawa T, Hiwasa T, Nakamura T, Ueno T, Kushibiki T, Takahashi M, Inoko K, Takano H, Takeuchi S, Dosaka-Akita H, Kuwatani M, Sakamoto N, Hatanaka Y, Mitsuhashi T, Shimada H, Shichinohe T, Hirano S.

Oncotarget. 2017 Oct 31;8(63):106206-106221. doi: 10.18632/oncotarget.22175. eCollection 2017 Dec 5.

32.

Fasciculation potentials and decremental responses in amyotrophic lateral sclerosis.

Miyaji Y, Hatanaka Y, Higashihara M, Kanbayashi T, Tanaka F, Sonoo M.

Clin Neurophysiol. 2017 Nov 21;129(2):345-348. doi: 10.1016/j.clinph.2017.11.007. [Epub ahead of print]

PMID:
29288989
33.
34.

Behavioral impairment in SHATI/NAT8L knockout mice via dysfunction of myelination development.

Sumi K, Uno K, Noike H, Tomohiro T, Hatanaka Y, Furukawa-Hibi Y, Nabeshima T, Miyamoto Y, Nitta A.

Sci Rep. 2017 Dec 4;7(1):16872. doi: 10.1038/s41598-017-17151-1.

35.

Image analysis is an excellent tool for quantifying Ki-67 to predict the prognosis of gastrointestinal stromal tumor patients.

Sugita S, Hirano H, Hatanaka Y, Fujita H, Kubo T, Kikuchi N, Ito Y, Sugawara T, Segawa K, Hisai H, Yamashita K, Nobuoka T, Matsuno Y, Hasegawa T.

Pathol Int. 2018 Jan;68(1):7-11. doi: 10.1111/pin.12611. Epub 2017 Nov 13.

PMID:
29131458
36.

Quantitative muscle ultrasound is useful for evaluating secondary axonal degeneration in chronic inflammatory demyelinating polyneuropathy.

Hokkoku K, Matsukura K, Uchida Y, Kuwabara M, Furukawa Y, Tsukamoto H, Hatanaka Y, Sonoo M.

Brain Behav. 2017 Sep 15;7(10):e00812. doi: 10.1002/brb3.812. eCollection 2017 Oct.

37.

The Anti-tumor Effect of Cabozantinib on Ovarian Clear Cell Carcinoma In Vitro and In Vivo.

Nakatani M, Watari H, Mitamura T, Wang L, Hatanaka Y, Hatanaka KC, Honda K, Nomura T, Nishihara H, Tanaka S, Sakuragi N.

Anticancer Res. 2017 Nov;37(11):6125-6132.

PMID:
29061793
38.

Retinal biometrics based on Iterative Closest Point algorithm.

Hatanaka Y, Tajima M, Kawasaki R, Saito K, Ogohara K, Muramatsu C, Sunayama W, Fujita H.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:373-376. doi: 10.1109/EMBC.2017.8036840.

PMID:
29059888
39.

Histone H3 Methylated at Arginine 17 Is Essential for Reprogramming the Paternal Genome in Zygotes.

Hatanaka Y, Tsusaka T, Shimizu N, Morita K, Suzuki T, Machida S, Satoh M, Honda A, Hirose M, Kamimura S, Ogonuki N, Nakamura T, Inoue K, Hosoi Y, Dohmae N, Nakano T, Kurumizaka H, Matsumoto K, Shinkai Y, Ogura A.

Cell Rep. 2017 Sep 19;20(12):2756-2765. doi: 10.1016/j.celrep.2017.08.088.

40.

Catalytic enantioselective aza-Diels-Alder reactions of unactivated acyclic 1,3-dienes with aryl-, alkenyl-, and alkyl-substituted imines.

Hatanaka Y, Nantaku S, Nishimura Y, Otsuka T, Sekikaw T.

Chem Commun (Camb). 2017 Aug 8;53(64):8996-8999. doi: 10.1039/c7cc03010j.

PMID:
28745730
41.

Cytopathologic findings of cell block materials from the vitreous: Diagnostic distinction between intraocular lymphoma and non-lymphomatous diseases.

Kanno-Okada H, Takakuwa E, Tagawa Y, Kase S, Hatanaka KC, Hatanaka Y, Namba K, Mitsuhashi T, Matsuno Y.

Pathol Int. 2017 Jul;67(7):342-349. doi: 10.1111/pin.12551. Epub 2017 Jun 7.

PMID:
28590047
42.

An unusual case of sodium channel myotonia with transient weakness upon initiating movements which is characteristic in Becker disease.

Yamamoto J, Hokkoku K, Hatanaka Y, Sakoda S, Yuan JH, Sonoo M.

Rinsho Shinkeigaku. 2017 Jun 28;57(6):287-292. doi: 10.5692/clinicalneurol.cn-000980. Epub 2017 May 26. Japanese.

PMID:
28552867
43.

Low-grade intraductal carcinoma (low-grade cribriform cystadenocarcinoma) with tumor-associated lymphoid proliferation of parotid gland.

Nishijima T, Yamamoto H, Nakano T, Hatanaka Y, Taguchi KI, Masuda M, Oda Y.

Pathol Res Pract. 2017 Jun;213(6):706-709. doi: 10.1016/j.prp.2017.02.019. Epub 2017 Feb 28.

PMID:
28551385
44.

Consideration of Dose Error in Dynamic MLC IMRT Using MLC Speed Control with Dose Rate Change.

Kojima H, Takigami M, Asano T, Hatanaka Y, Aizawa K, Ishikawa M.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(5):382-388. doi: 10.6009/jjrt.2017_JSRT_73.5.382. Japanese.

45.

Amyotrophic lateral sclerosis with a sudden-onset history.

Kanbayashi T, Mikata T, Hatanaka Y, Sonoo M.

Clin Neurophysiol Pract. 2017 May 6;2:103-104. doi: 10.1016/j.cnp.2017.04.003. eCollection 2017.

46.

The Rodent-Specific MicroRNA Cluster within the Sfmbt2 Gene Is Imprinted and Essential for Placental Development.

Inoue K, Hirose M, Inoue H, Hatanaka Y, Honda A, Hasegawa A, Mochida K, Ogura A.

Cell Rep. 2017 May 2;19(5):949-956. doi: 10.1016/j.celrep.2017.04.018.

47.

Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report.

Tanaka S, Haketa A, Yamamuro S, Suzuki T, Kobayashi H, Hatanaka Y, Ueno T, Fukuda N, Abe M, Yoshino A, Soma M.

J Diabetes Investig. 2018 Jan;9(1):223-225. doi: 10.1111/jdi.12675. Epub 2017 Jun 26.

48.

Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.

Ohata T, Yokoo H, Kamiyama T, Fukai M, Aiyama T, Hatanaka Y, Hatanaka K, Wakayama K, Orimo T, Kakisaka T, Kobayashi N, Matsuno Y, Taketomi A.

Cancer Med. 2017 May;6(5):1049-1061. doi: 10.1002/cam4.1020. Epub 2017 Apr 4.

49.

Utility of repetitive nerve stimulation test for ALS diagnosis.

Hatanaka Y, Higashihara M, Chiba T, Miyaji Y, Kawamura Y, Sonoo M.

Clin Neurophysiol. 2017 May;128(5):823-829. doi: 10.1016/j.clinph.2017.02.021. Epub 2017 Mar 6.

PMID:
28340431
50.

Artery and vein diameter ratio measurement based on improvement of arteries and veins segmentation on retinal images.

Hatanaka Y, Tachiki H, Ogohara K, Muramatsu C, Okumura S, Fujita H.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:1336-1339. doi: 10.1109/EMBC.2016.7590954.

PMID:
28268572

Supplemental Content

Loading ...
Support Center